1. Home
  2. NURO vs IMCC Comparison

NURO vs IMCC Comparison

Compare NURO & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • IMCC
  • Stock Information
  • Founded
  • NURO 1996
  • IMCC 1980
  • Country
  • NURO United States
  • IMCC Israel
  • Employees
  • NURO N/A
  • IMCC N/A
  • Industry
  • NURO Medical/Dental Instruments
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • NURO Health Care
  • IMCC Health Care
  • Exchange
  • NURO Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • NURO 8.2M
  • IMCC 7.5M
  • IPO Year
  • NURO N/A
  • IMCC N/A
  • Fundamental
  • Price
  • NURO $4.38
  • IMCC $2.37
  • Analyst Decision
  • NURO
  • IMCC
  • Analyst Count
  • NURO 0
  • IMCC 0
  • Target Price
  • NURO N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • NURO 21.4K
  • IMCC 17.6K
  • Earning Date
  • NURO 02-20-2025
  • IMCC 03-27-2025
  • Dividend Yield
  • NURO N/A
  • IMCC N/A
  • EPS Growth
  • NURO N/A
  • IMCC N/A
  • EPS
  • NURO N/A
  • IMCC N/A
  • Revenue
  • NURO $3,767,764.00
  • IMCC $38,042,859.00
  • Revenue This Year
  • NURO N/A
  • IMCC $22.59
  • Revenue Next Year
  • NURO N/A
  • IMCC $32.86
  • P/E Ratio
  • NURO N/A
  • IMCC N/A
  • Revenue Growth
  • NURO N/A
  • IMCC N/A
  • 52 Week Low
  • NURO $2.66
  • IMCC $1.44
  • 52 Week High
  • NURO $4.73
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.97
  • IMCC 53.35
  • Support Level
  • NURO $4.16
  • IMCC $2.05
  • Resistance Level
  • NURO $4.40
  • IMCC $2.60
  • Average True Range (ATR)
  • NURO 0.09
  • IMCC 0.21
  • MACD
  • NURO 0.03
  • IMCC 0.02
  • Stochastic Oscillator
  • NURO 95.24
  • IMCC 58.31

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: